The clinical effect of a new infant formula in term infants with constipation: a double-blind, randomized cross-over trial
2007

New Formula Helps Constipated Infants

Sample size: 38 publication 10 minutes Evidence: moderate

Author Information

Author(s): Bongers Marloes EJ, Lorijn Fleur, Reitsma Johannes B, Groeneweg Michael, Taminiau Jan AJM, Benninga Marc A

Primary Institution: Academic Medical Centre, Amsterdam, The Netherlands

Hypothesis

The new infant formula (Nutrilon Omneo) positively affects stool characteristics in constipated infants.

Conclusion

The new formula may lead to softer stools in constipated infants, but does not significantly change defecation frequency.

Supporting Evidence

  • Infants fed the new formula had a higher percentage of softer stools compared to those fed the standard formula.
  • Defecation frequency increased significantly from baseline in both groups.
  • The new formula was well tolerated with no serious adverse effects reported.

Takeaway

A new baby formula can help babies with constipation have softer poop, but it doesn't make them go to the bathroom more often.

Methodology

A double-blind, randomized cross-over trial with 38 constipated infants aged 3–20 weeks comparing a new formula to a standard formula.

Potential Biases

Drop-out related to clinical outcomes may bias results.

Limitations

High drop-out rate may introduce bias and limit the findings.

Participant Demographics

38 constipated infants, median age 1.7 months, 19 male.

Statistical Information

P-Value

0.001

Confidence Interval

95% CI: 0.81 – 2.78

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1475-2891-6-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication